Global Single-use Bioprocessing Market Outlook and Forecast 2021-2026: High Uptake of Biopharmaceuticals & Biosimilars

Dublin, April 06, 2021 (GLOBE NEWSWIRE) -- The "Single-use Bioprocessing Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Single-use Bioprocessing Market Report

The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during the period 2021-2026.

The outbreak of the COVID-19 pandemic has boosted the demand for single-use bioprocessing (SUB) technology. The ongoing robust R&D activities and clinical studies on the Covid-19 vaccine are encouraging many stakeholders to use SUB technology. Modalities such as covid-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the single-use bioprocessing market growth. The majority of biomanufacturing companies rely on advanced technology such as single-use systems to develop the vaccine.t.

Global Single-Use Bioprocessing Market Segmentation

The global single-use bioprocessing market research report includes a detailed segmentation by product, application, end-user, method, geography. Single-use bioprocessing products are observing growth due to advances in equipment, higher scalability, and the increased application in the biopharmaceutical industry. Bioreactors and fermenters cover significant shares among SUB. The use of bioreactors and fermenters is growing for the development of biosimilars & biologics.

The availability of single-use chromatography systems is considered a solution for single-use downstream bioprocessing. The use of membrane formats, scaling technologies, ion exchange technology, and polymeric column constructions is shifting end-users toward SUBs in downstream processes. Chromatography systems combined with tangential flow filtrations provide the highest productivity in downstream separation and purification steps.

The increased application of monoclonal antibodies (mABs) for the diagnosis and treatment of autoimmune disorders, cancer, and sexually transmitted infections (STIs) is boosting the single-use bioprocessing market growth. The production of mABs via single-use bioreactors reduces the operating cost and offers more flexibility than traditional stainless steel equipment. Also, the use of SUB in mABs manufacturing increases capacity, productivity, and flexibility.

The utilization of SUBs in vaccine manufacturing is catching pace and is considered the smart method, especially during pandemics. They have become an ideal choice among manufacturers as they can be manufactured in a short time and do not require validation and have a reduced risk of contamination. Furthermore, single-use systems help enhance flexibility in small and large vaccine manufacturing and produce multiple products in a single suite.

Biopharmaceutical manufacturers occupy a significant share of the market, with single-use systems witnessing adoption in pre-commercial production processes. Several biopharmaceutical manufacturers have started to explore these solutions in commercial manufacturing. However, their potential benefits are significant, particularly for small-volume manufacturing in modular facilities. With the advent of single-use bioprocessing, the bioprocessing industry's dynamics have changed, enabling companies to develop new biologics with higher flexibility and low upfront costs. As technology has become increasingly popular, many companies are becoming interested in the widespread adoption of single-use bioprocessing.

Advances in the cell culture process and biopharmaceutical manufacturing is leading to the development of innovative single-use technology. Single-use bioreactors are increasingly used for animal and human cell production processes. SUBs in mammalian cell culture result in high flexibility, reduced cost, and enhanced product productivity. They are increasingly being used for small-batch, large-batch volumes, clinical trials, and process development.

Insights by Vendors

Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Danaher Corporation, and Avantor are the key vendors operating in the global single-use bioprocessing market. The key players are increasing their focus on mergers and acquisitions in the past few years.

With the sudden onset of the COVID-19 pandemic, vendors target vaccine developers and offer customized and flexible SUB technology. Acquisitions of emerging/small, specialized single-use suppliers, product portfolio development, expansion in regional markets, and strengthening of global distribution networks are the major strategies adopted by vendors in the market.

Prominent Vendors

• Thermo Fisher Scientific

• Sartorius Stedim Biotech

• Danaher

• Merck KGaA

• Avantor

Other Prominent Vendors

• Applikon Biotechnology

• Eppendorf

• CESCO Bioengineering

• Corning

• Rentschler Biopharma SE

• Entegris

• Meissner Filtration Products

• Parker-Hannifin Corporation

• PBS Biotech Inc.

• Saint-Gobain

• Sentinel Process Systems

• ABEC

• Adolf Kuhner

• Charter Medical

• Holland Applied Technologies

• Repligen

• Solaris Biotech Solutions

• 3M Company

• Lonza

• Pneumatic Scale Angelus

• ARTeSYN Biosolutions

• Wego Group

• Distek

• New Horizon Biotech

• OmniBRx Biotechnologies

• Yposkesi

• Charge Point Technology

• High Purity New England

• PendoTECH

• AdvantaPure

• TBL Performance Plastics

• Cellon

• Sysbiotech

• Broadley-James

• CerCell A/S

• PreSens-Precision Sensing GmbH

• Emerson Electric Co.

• Colder Products Company (CPC)

• Watson-Marlow Fluid Technology Group

• Foxx Life Sciences

• DrM (Dr. Mueller AG)
  W.L. Gore & Associates

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of The Study

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.2 Single-Use Bioprocessing: Market Snapshot

8 Market Opportunities & Trends
8.1 Increasing Strategic Acquisitions & Partnerships
8.2 New Product Launches
8.3 High Utilization of Single-Use Bioprocessing For COVID-19 Vaccine Production
8.4 Technological Advances Witnessed In SUB

9 Market Growth Enablers
9.1 Increasing Adoption of Single-Use Technologies Over Multi-Use Platforms
9.2 Reduced Water Consumption and Lesser Environment Impact Of Single-Use Technologies
9.3 Lower Risk of Cross Contamination and Lower Manufacturing Cost
9.4 High Uptake of Biopharmaceuticals & Biosimilars
9.5 Increasing Demand for Flexible Bioprocessing And Less Floor Space Requirements

10 Market Restraints
10.1 Leachables & Extractables With Single-Use Bioprocessing
10.2 High-Cost of Single-Use Bioprocessing
10.3 Challenges With Scalability, Product Compatibility And Compliance
10.4 Regulatory Uncertainties Impacting the Adoption of Single-Use Bioprocessing

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Single-Use Bioprocessing Equipment
12.4 Simple & Peripheral Elements

13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Monoclonal Antibodies
13.4 Vaccines
13.5 Cell Therapies
13.6 Others

14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Biopharmaceutical Manufacturers
14.4 CMOs
14.5 R&D Companies and Research Institutes

15 Method
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Filtration
15.4 Storage & Transport
15.5 Cell Culture
15.6 Mixing
15.7 Purification

For more information about this report visit https://www.researchandmarkets.com/r/gq41pn

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900